Update on the NICE ME/CFS guideline roundtable discussion
The roundtable meeting to discuss the updated guideline on the diagnosis and management of ME/CFS will be held on October 18th in London. It is being convened after publication of the guideline was paused when issues were raised by some professional groups during the pre-publication period.
-
NICE and PHE recommend all employers give mental health training for managers
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
-
Professor Gillian Leng to retire from NICE
Professor Leng has spent more than 20 years working at NICE
-
NICE recommends treatment for people with juvenile idiopathic arthritis
NICE has today (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
